Fluidx Medical Technology, Inc.

Fluidx Medical Technology, Inc. is a medical device company located in Salt Lake City, Utah. The company specializes in developing innovative embolic devices to enhance embolization procedures. Their flagship product, the GPX Embolic Device, is a durable liquid embolic material that is easy to prepare, controllable, and highly visible during delivery. It is designed for vessel occlusion in various clinical applications, including oncology, hemorrhage control, and neurovascular interventions. Fluidx Medical is dedicated to improving patient safety and clinical outcomes through their advanced embolization technologies. Their leadership team comprises experienced entrepreneurs and interventional physicians with backgrounds in cardiovascular and interventional radiology. The company is actively involved in clinical trials and has received Investigational Device Exemption (IDE) approval for pivotal trials of the GPX Embolic Device, indicating progress toward regulatory clearance and market entry. They are also developing additional products, including the ULTRA Peripheral Embolic Platform and the IMPASS Embolic Device, to further expand their offerings in the embolization market.

• Employees 7
• Founded 2015
• Total Funding $8826003